BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martin J, Petrillo A, Smyth EC, Shaida N, Khwaja S, Cheow H, Duckworth A, Heister P, Praseedom R, Jah A, Balakrishnan A, Harper S, Liau S, Kosmoliaptsis V, Huguet E. Colorectal liver metastases: Current management and future perspectives. World J Clin Oncol 2020; 11(10): 761-808 [PMID: 33200074 DOI: 10.5306/wjco.v11.i10.761] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Adam R, Accardo C, Allard M. Cytoreductive surgery for colorectal liver metastases: is it worthwhile? Minerva Surg 2022;77. [DOI: 10.23736/s2724-5691.22.09669-1] [Reference Citation Analysis]
2 Papakonstantinou M, Fiflis S, Christodoulidis G, Giglio MC, Louri E, Mavromatidis S, Giakoustidis D, Papadopoulos VN, Giakoustidis A. Neutrophil-to-lymphocyte ratio as a prognostic factor for survival in patients with colorectal liver metastases: A systematic review. World J Clin Oncol 2022; 13(10): 822-834 [DOI: 10.5306/wjco.v13.i10.822] [Reference Citation Analysis]
3 Liang F, Nilsson LM, Byvald F, Rezapour A, Taflin H, Nilsson JA, Yrlid U. A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells. Cancers (Basel) 2022;14:2882. [PMID: 35740548 DOI: 10.3390/cancers14122882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mohamad I, Barry A, Dawson L, Hosni A. Stereotactic body radiation therapy for colorectal liver metastases. International Journal of Hyperthermia 2022;39:611-9. [DOI: 10.1080/02656736.2021.1923836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Burlaka AA, Makhmudov DE, Lisnyi II, Paliichuk AV, Zvirych VV, Lukashenko AV. Parenchyma-sparing strategy and oncological prognosis in patients with colorectal cancer liver metastases. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02579-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wrana F, Dötzer K, Prüfer M, Werner J, Mayer B. High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy. Cancers (Basel) 2022;14:1939. [PMID: 35454846 DOI: 10.3390/cancers14081939] [Reference Citation Analysis]
7 Paro A, Hyer MJ, Tsilimigras DI, Guglielmi A, Ruzzenente A, Alexandrescu S, Poultsides G, Aucejo F, Cloyd JM, Pawlik TM. Machine Learning Approach to Stratifying Prognosis Relative to Tumor Burden after Resection of Colorectal Liver Metastases: An International Cohort Analysis. J Am Coll Surg 2022;234:504-13. [PMID: 35290269 DOI: 10.1097/XCS.0000000000000094] [Reference Citation Analysis]
8 Banchini F, Luzietti E, Palmieri G, Bonfili D, Romboli A, Conti L, Capelli P. Laparoscopic Resection of Synchronous Liver Metastasis Involving the Left Hepatic Vein and the Common Trunk Bifurcation: A Strategy of Parenchyma-Sparing Resection with Left Sectionectomy and 4a Subsegmentectomy by Arantius Approach. Healthcare 2022;10:517. [DOI: 10.3390/healthcare10030517] [Reference Citation Analysis]
9 Poghosyan S, Frenkel N, Lentzas A, Laoukili J, Rinkes IB, Kranenburg O, Hagendoorn J. Loss of Neuropilin-2 in Murine Mesenchymal-like Colon Cancer Organoids Causes Mesenchymal-to-Epithelial Transition and an Acquired Dependency on Insulin-Receptor Signaling and Autophagy. Cancers 2022;14:671. [DOI: 10.3390/cancers14030671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Guz M, Jeleniewicz W, Cybulski M. An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential. Int J Mol Sci 2022;23:1234. [PMID: 35163157 DOI: 10.3390/ijms23031234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lewin M. Optimal Diagnostic Imaging of CLM for Surgical Candidates. Colorectal Liver Metastasis 2022. [DOI: 10.1007/978-3-031-09323-4_38] [Reference Citation Analysis]
12 Rubbia-brandt L. Hepatic Injury from Chemotherapy. Colorectal Liver Metastasis 2022. [DOI: 10.1007/978-3-031-09323-4_44] [Reference Citation Analysis]
13 Hadjittofi C, Feretis M, Martin J, Harper S, Huguet E. Liver regeneration biology: Implications for liver tumour therapies. World J Clin Oncol 2021; 12(12): 1101-1156 [DOI: 10.5306/wjco.v12.i12.1101] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Wang ZJ, Zheng SH, Wang XH, Zhang YZ, Hao SL, Liu LK, Wang XX. Buzhong Tiaogan Formula for delaying colorectal liver metastasis (liver depression spleen deficient type): A multicenter randomized controlled trial: A study protocol. Medicine (Baltimore) 2021;100:e28040. [PMID: 34941044 DOI: 10.1097/MD.0000000000028040] [Reference Citation Analysis]
15 Hu D, Pan Y, Chen G. Colorectal cancer liver metastases: An update of treatment strategy and future perspectives. Surgery in Practice and Science 2021;7:100042. [DOI: 10.1016/j.sipas.2021.100042] [Reference Citation Analysis]
16 Ye T, Zhu P, Liu Z, Ren Q, Zheng C, Xia X. Liver abscess after drug-eluting bead chemoembolization in patients with metastatic hepatic tumors. Br J Radiol 2021;:20211056. [PMID: 34762523 DOI: 10.1259/bjr.20211056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 He XS, Zou SY, Yao JL, Yu W, Deng ZY, Wang JR, Gan WJ, Wan S, Yang XQ, Wu H. Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer. Front Mol Biosci 2021;8:763652. [PMID: 34722636 DOI: 10.3389/fmolb.2021.763652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hu X, Chen Q, Guo H, Li K, Fu B, Chen Y, Zhao H, Wei M, Li Y, Wu H. Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis. Front Oncol 2021;11:657984. [PMID: 34490081 DOI: 10.3389/fonc.2021.657984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Rasic P, Jovanovic-Tucovic M, Jeremic M, Djuricic SM, Vasiljevic ZV, Milickovic M, Savic D. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World J Gastrointest Oncol 2021; 13(8): 799-821 [PMID: 34457187 DOI: 10.4251/wjgo.v13.i8.799] [Reference Citation Analysis]
20 Osei-Bordom DC, Kamarajah S, Christou N. Colorectal Cancer, Liver Metastases and Biotherapies. Biomedicines 2021;9:894. [PMID: 34440099 DOI: 10.3390/biomedicines9080894] [Reference Citation Analysis]
21 Diehl TM, Abbott DE. Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer. Curr Treat Options Oncol 2021;22:82. [PMID: 34224023 DOI: 10.1007/s11864-021-00878-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Zhao J, Zhu J, Sun R, Huang C, Yuan R, Zhu Z. Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis. BMC Cancer 2021;21:503. [PMID: 33957871 DOI: 10.1186/s12885-021-08157-0] [Reference Citation Analysis]
23 Romayor I, Márquez J, Benedicto A, Herrero A, Arteta B, Olaso E. Tumor DDR1 deficiency reduces liver metastasis by colon carcinoma and impairs stromal reaction. Am J Physiol Gastrointest Liver Physiol 2021;320:G1002-13. [PMID: 33851541 DOI: 10.1152/ajpgi.00078.2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Moran BJ, Guerra GR. Randomized controlled trials in surgical resection of colorectal peritoneal metastases: Disentangling negativity in PRODIGE 7 and PROPHYLOCHIP. Colorectal Dis 2021;23:1303-5. [PMID: 33615659 DOI: 10.1111/codi.15596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
25 Kubal C, Mihaylov P, Holden J. Oncologic indications of liver transplantation and deceased donor liver allocation in the United States. Curr Opin Organ Transplant 2021;26:168-75. [PMID: 33650998 DOI: 10.1097/MOT.0000000000000866] [Cited by in F6Publishing: 1] [Reference Citation Analysis]